Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 12/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 12/20 | 0.34 |
| ▸ | RXRA | P19793 | 8/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17979255 | 0.85 | UHRF1 (0.35) | KCNH2UHRF1GRIN1GRIN2BRXRA | |
| SCHEMBL22299273 | 0.81 | LMNA (0.39) | UHRF1CYP1A2CYP2A6 | |
| SCHEMBL18018351 | 0.76 | UHRF1 (0.48) | UHRF1CYP1A2CYP2A6KDM4ETSHR | |
| SCHEMBL22445234 | 0.75 | UHRF1 (0.39) | UHRF1CYP1A2CYP2A6KDM4ETSHR | |
| SCHEMBL34472156 | 0.75 | NNMT (0.44) | KCNH2GRIN1GRIN2BRXRA | |
| SCHEMBL22299472 | 0.75 | CNR2 (0.32) | UHRF1CYP1A2CYP2A6 | |
| SCHEMBL29911632 | 0.72 | UHRF1 (0.40) | UHRF1CYP1A2CYP2A6KDM4ETSHR | |
| SCHEMBL3706312 | 0.72 | — | — | |
| SCHEMBL10144238 | 0.71 | — | — | |
| SCHEMBL20285928 | 0.71 | LMNA (0.42) | UHRF1CYP1A2CYP2A6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200390100-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AG (DE) | 2020-12-17 | — | — | US | disclosed |
| WO-2018114596-A1 | SUBSTITUTED HETEROARYL PYRROLONES AND SALTS THEREOF AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390100-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | DDT, NOTUM, AGPS | KCNH2 1508/4885UHRF1 3487/4885GRIN1 1129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.